(Q33844388)

29 July 2017

1 reference

title

Diffuse panbronchiolitis: role of macrolides in therapy (English)

1 reference

29 July 2017

diffuse panbronchiolitis

1 reference

Naoto Keicho

1

1 reference

PubMed ID

14720066

29 July 2017

Shoji Kudoh

series ordinal

2

1 reference

29 July 2017

1 January 2002

1 reference

Treatments in Respiratory Medicine

29 July 2017

1 reference

29 July 2017

1

1 reference

29 July 2017

2

1 reference

29 July 2017

119-131

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256601

29 July 2017

0 references

cites work

Diffuse panbronchiolitis. A disease of the transitional zone of the lung

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

The first report of diffuse panbronchiolitis in Korea: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Clinical profiles of Chinese patients with diffuse panbronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

A case of diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis in an Asian immigrant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Analysis of HLA antigens in patients with diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis and cystic fibrosis: East meets West

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Genetic variations in the 5-lipoxygenase core promoter. Description and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Pathogenesis of lung disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

New approaches to optimizing antimicrobial therapy in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Small airways diseases: detection and insights with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Centrilobular nodules correlate with air trapping in diffuse panbronchiolitis during erythromycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Erythromycin and diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Anti-inflammatory effects of macrolides in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

The anti-inflammatory effects of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse panbronchiolitis--pathophysiology and treatment mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Macrolide antibiotics and pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Anti-inflammatory effects of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Erythromycin shortens neutrophil survival by accelerating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Macrolides for the treatment of Pseudomonas aeruginosa infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

The involvement of cell-to-cell signals in the development of a bacterial biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Azithromycin, the multidrug-resistant protein, and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

Diffuse Panbronchiolitis: Eine seltene Differentialdiagnose der chronisch-obstruktiven Lungenkrankheit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256601

21 January 2018

Identifiers

DOI

10.1007/BF03256601

1 reference

29 July 2017

1 reference

PubMed ID

14720066